Philadelphia Prostate Cancer Genetic Consensus Conference 2019 and implications for military medicine

Cord J. Peters; Clesson E. Turner; Gregory T. Chesnut; Veda N. Giri; Leonard G. Gomella; Craig D. Shriver; Albert Dobi

Philadelphia Prostate Cancer Genetic Consensus Conference 2019 and implications for military medicine

Cord J. Peters, Clesson E. Turner, Gregory T. Chesnut, Veda N. Giri, Leonard G. Gomella, Craig D. Shriver, Albert Dobi^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

Introduction: The objective of our review is to summarize the 2019 Philadelphia Prostate Cancer Genetic Consensus recommendations and discuss their implications to the US Military Health System. Materials and methods: Literature review. Results: Our fighting force and retired service members will significantly benefit from the Philadelphia Prostate Cancer Genetic Consensus recommendations. Moreover, the experience of the equal access US Military Health System may help advancing genetic testing for cancer at national levels. Conclusions: Priorities recommended by the 2019 Consensus for more research on genetic predisposition to prostate cancer in racially diverse populations is a promising step. The US Military Health System has the ability of providing equal access to implement advanced germline testing for its racially diverse population.

Original language	English
Pages (from-to)	10659-10667
Number of pages	9
Journal	Canadian Journal of Urology
Volume	28
Issue number	3
State	Published - 2021
Externally published	Yes

Keywords

Military Healthcare System
cancer genomics
genetic testing
prostate cancer

Cite this

@article{46bebeb1ec8840d6ad95df1267b7fc04,

title = "Philadelphia Prostate Cancer Genetic Consensus Conference 2019 and implications for military medicine",

abstract = "Introduction: The objective of our review is to summarize the 2019 Philadelphia Prostate Cancer Genetic Consensus recommendations and discuss their implications to the US Military Health System. Materials and methods: Literature review. Results: Our fighting force and retired service members will significantly benefit from the Philadelphia Prostate Cancer Genetic Consensus recommendations. Moreover, the experience of the equal access US Military Health System may help advancing genetic testing for cancer at national levels. Conclusions: Priorities recommended by the 2019 Consensus for more research on genetic predisposition to prostate cancer in racially diverse populations is a promising step. The US Military Health System has the ability of providing equal access to implement advanced germline testing for its racially diverse population.",

keywords = "Military Healthcare System, cancer genomics, genetic testing, prostate cancer",

author = "Peters, {Cord J.} and Turner, {Clesson E.} and Chesnut, {Gregory T.} and Giri, {Veda N.} and Gomella, {Leonard G.} and Shriver, {Craig D.} and Albert Dobi",

note = "Publisher Copyright: {\textcopyright} The Canadian Journal of Urology TM;28(3):June 2021",

year = "2021",

language = "English",

volume = "28",

pages = "10659--10667",

journal = "Canadian Journal of Urology",

issn = "1195-9479",

number = "3",

}

TY - JOUR

T1 - Philadelphia Prostate Cancer Genetic Consensus Conference 2019 and implications for military medicine

AU - Peters, Cord J.

AU - Turner, Clesson E.

AU - Chesnut, Gregory T.

AU - Giri, Veda N.

AU - Gomella, Leonard G.

AU - Shriver, Craig D.

AU - Dobi, Albert

N1 - Publisher Copyright: © The Canadian Journal of Urology TM;28(3):June 2021

PY - 2021

Y1 - 2021

N2 - Introduction: The objective of our review is to summarize the 2019 Philadelphia Prostate Cancer Genetic Consensus recommendations and discuss their implications to the US Military Health System. Materials and methods: Literature review. Results: Our fighting force and retired service members will significantly benefit from the Philadelphia Prostate Cancer Genetic Consensus recommendations. Moreover, the experience of the equal access US Military Health System may help advancing genetic testing for cancer at national levels. Conclusions: Priorities recommended by the 2019 Consensus for more research on genetic predisposition to prostate cancer in racially diverse populations is a promising step. The US Military Health System has the ability of providing equal access to implement advanced germline testing for its racially diverse population.

AB - Introduction: The objective of our review is to summarize the 2019 Philadelphia Prostate Cancer Genetic Consensus recommendations and discuss their implications to the US Military Health System. Materials and methods: Literature review. Results: Our fighting force and retired service members will significantly benefit from the Philadelphia Prostate Cancer Genetic Consensus recommendations. Moreover, the experience of the equal access US Military Health System may help advancing genetic testing for cancer at national levels. Conclusions: Priorities recommended by the 2019 Consensus for more research on genetic predisposition to prostate cancer in racially diverse populations is a promising step. The US Military Health System has the ability of providing equal access to implement advanced germline testing for its racially diverse population.

KW - Military Healthcare System

KW - cancer genomics

KW - genetic testing

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85108247137&partnerID=8YFLogxK

M3 - Article

C2 - 34129457

AN - SCOPUS:85108247137

SN - 1195-9479

VL - 28

SP - 10659

EP - 10667

JO - Canadian Journal of Urology

JF - Canadian Journal of Urology

IS - 3

ER -

Philadelphia Prostate Cancer Genetic Consensus Conference 2019 and implications for military medicine

Abstract

Keywords

Fingerprint

Cite this